Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plinabulin + Docetaxel in Advanced Non-squamous NSCLC (DUBLIN-4)
NCT07361484Phase 3Not yet recruiting
- Sponsor
- BeyondSpring Inc.
- Start
- Dec 2026
- Primary completion
- Jun 2029
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of plinabulin in non-small cell lung cancer (NSCLC), sponsored by BeyondSpring Inc.. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
plinabulin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT07361484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07361484.